Lori Harkins, MD
Ophthalmology · Grand Island, NENPI 1154322501
Payments from drug & device makers
Across 7 payments — averaging $42.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Align Ophthalmics LLC$85
- The Cameron-ehlen Group, Inc.$58
- Rayner Intraocular Lenses Limited$50
- Apellis Pharmaceuticals, Inc.$48
- Carl Zeiss Meditec AG$39
- Oyster Point Pharma, Inc.$20
What the payments were for
- Food & beverage$26187%
- Gifts$3913%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Align Ophthalmics LLC | 1 | $85 |
| The Cameron-ehlen Group, Inc. | 1 | $58 |
| Rayner Intraocular Lenses Limited | 1 | $50 |
| Apellis Pharmaceuticals, Inc. | 1 | $48 |
| Carl Zeiss Meditec AG | 2 | $39 |
| Oyster Point Pharma, Inc. | 1 | $20 |
How this compares
$299 in reported general payments places this provider in the 25th percentile of 105 ophthalmology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 152 | $107,996 |
| LumiganBimatoprost | 114 | $37,253 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 106 | $25,995 |
| XiidraLifitegrast | 38 | $25,542 |
| Alphagan PBrimonidine Tartrate | 56 | $20,432 |
| Cyclosporine | 64 | $19,285 |
| RhopressaNetarsudil Mesylate | 49 | $16,164 |
| RocklatanNetarsudil Mesylat/Latanoprost | 34 | $15,365 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 393 | $8,012 |
| Latanoprost | 733 | $7,307 |
| CombiganBrimonidine Tartrate/Timolol | 27 | $7,072 |
| Prednisolone Acetate | 164 | $5,902 |
| Brimonidine Tartrate | 123 | $4,985 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 23 | $4,102 |
| LotemaxLoteprednol Etabonate | 12 | $3,846 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Grand Island
- Michele GleasonGrand Island$2K
- Julie JankyGrand Island$2K
- Brandon BaartmanOmaha$1.7M
- Lorraine ProvencherOmaha$348K
- Ronald KruegerOmaha$279K
- Lance KuglerOmaha$95K
- Rao ChunduryOmaha$69K
- Samiksha Fouzdar JainOmaha$23K
- Shane HavensOmaha$8K
- Brandon MenkeOmaha$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.